Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 679

Results For "CE"

9359 News Found

IMCD Colombia acquires pharma API distributor Allianz
Supply Chain | May 03, 2023

IMCD Colombia acquires pharma API distributor Allianz

Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market


CPHI & PMEC China 2023 to see surge from pent up international ingredients demand
News | May 03, 2023

CPHI & PMEC China 2023 to see surge from pent up international ingredients demand

China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey


Majority of UK physicians believe Brexit aggravated NHS staff shortage crisis: GlobalData
News | May 02, 2023

Majority of UK physicians believe Brexit aggravated NHS staff shortage crisis: GlobalData

Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis


Mitsui Chemicals ‘Super-Bond’ dental adhesive to launch in Brazil
News | May 01, 2023

Mitsui Chemicals ‘Super-Bond’ dental adhesive to launch in Brazil

Super-Bond is made up of a polymerization initiator, a liquid and a polymer powder


Aarti Drugs reports Q4 FY23 PAT at Rs.56.02 Cr
News | April 30, 2023

Aarti Drugs reports Q4 FY23 PAT at Rs.56.02 Cr

Specialty Chemicals grew 38% YoY for FY23


Atul appoints Rangaswamy Iyer as Independent Director
People | April 29, 2023

Atul appoints Rangaswamy Iyer as Independent Director

The appointment is effective from May 01, 2023 for five years


TPAG organizes Thalassemia & SCD prevention discussion
News | April 29, 2023

TPAG organizes Thalassemia & SCD prevention discussion

The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally


Yuyu Pharma unveils the results of its studies for its dry eye treatment peptide
News | April 28, 2023

Yuyu Pharma unveils the results of its studies for its dry eye treatment peptide

The YP-P10 pre-clinical head-to-head study, jointly conducted by five people including Dr. Kyungho Park of Naason Science


Cipla partners with MNCs to strengthen anti-diabetes innovative portfolio: GlobalData
News | April 28, 2023

Cipla partners with MNCs to strengthen anti-diabetes innovative portfolio: GlobalData

Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.


Laurus Labs Q4 FY23 consolidated PAT drops to to Rs. 102.98 Cr
News | April 28, 2023

Laurus Labs Q4 FY23 consolidated PAT drops to to Rs. 102.98 Cr

Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects